These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 29120754)

  • 1. New Opportunities and Challenges to Defeat Cancer Stem Cells.
    Ramos EK; Hoffmann AD; Gerson SL; Liu H
    Trends Cancer; 2017 Nov; 3(11):780-796. PubMed ID: 29120754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness.
    Ma Y; Shen N; Wicha MS; Luo M
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.
    Keyvani-Ghamsari S; Khorsandi K; Rasul A; Zaman MK
    Clin Epigenetics; 2021 May; 13(1):120. PubMed ID: 34051847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17B/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination.
    Bie Q; Song H; Chen X; Yang X; Shi S; Zhang L; Zhao R; Wei L; Zhang B; Xiong H; Zhang B
    Oncogene; 2021 Mar; 40(12):2200-2216. PubMed ID: 33649532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.
    Zhou HM; Zhang JG; Zhang X; Li Q
    Signal Transduct Target Ther; 2021 Feb; 6(1):62. PubMed ID: 33589595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cells and Treatment of Cancer: An Update and Future Perspectives.
    Khan M; Naeem M; Chaudary SA; Ahmed A; Ahmed A
    Curr Stem Cell Res Ther; 2024; 19(10):1312-1320. PubMed ID: 37818567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The strategies to cure cancer patients by eradicating cancer stem-like cells.
    Mai Y; Su J; Yang C; Xia C; Fu L
    Mol Cancer; 2023 Oct; 22(1):171. PubMed ID: 37853413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Cancer Stem Cells and Stemness for Community Oncologists.
    Lathia JD; Liu H
    Target Oncol; 2017 Aug; 12(4):387-399. PubMed ID: 28664387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of targeting cancer stem cells to halt metastasis.
    Agliano A; Calvo A; Box C
    Semin Cancer Biol; 2017 Jun; 44():25-42. PubMed ID: 28323021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells: a potential target for cancer therapy.
    Qiu H; Fang X; Luo Q; Ouyang G
    Cell Mol Life Sci; 2015 Sep; 72(18):3411-24. PubMed ID: 25967289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells and differentiation therapy.
    Jin X; Jin X; Kim H
    Tumour Biol; 2017 Oct; 39(10):1010428317729933. PubMed ID: 29072131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance.
    Eid RA; Alaa Edeen M; Shedid EM; Kamal ASS; Warda MM; Mamdouh F; Khedr SA; Soltan MA; Jeon HW; Zaki MSA; Kim B
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
    Shan NL; Shin Y; Yang G; Furmanski P; Suh N
    Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
    Chen K; Huang YH; Chen JL
    Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.